21021 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof Enzymes; Proenzymes; Derivatives thereof
Sub-classes:Compositions and Methods for the Treatment of ATPase Disorders or Diseases of the Skin
#2ATP7B GENE THERAPY
#3CALSEQUESTRIN-BASED METAL ION REACTIVE PARTICLE AND USES THEREOF
#4ENGINEERED CELLS AND IMPLANTABLE ELEMENTS FOR TREATMENT OF DISEASE
#5PARTICLES, METHOD FOR PRODUCING PARTICLES, AND PHARMACEUTICAL COMPOSITION
#6FUNGAL SPECIES, COMPOSITIONS DERIVED THEREFROM, AND USES THEREOF
#7Treatment Method and Product for Uterine Fibroids using Purified Collagenase
#8PIC1 INHIBITION OF MYELOPEROXIDASE OXIDATIVE ACTIVITY IN AN ANIMAL MODEL
#9ACID REFLUX AND HEARTBURN CURING COMPOSITION
#10TARGETING NANOENZYME FOR MITIGATING CHEMOTHERAPY-INDUCED CARDIOTOXICITY, PREPARATION METHOD
#11Treatment Method and Product for Uterine Fibroids using Purified Collagenase
#12BACTERIOPHAGE LYSINE, CHIMERA THEREOF AND APPLICATION THEREOF
#13BIOLOGICAL ENZYME FOR KILLING VIRUSES AND PREPARATION METHOD THEREOF
#14ANTIVIRAL ANIMAL FEED ADDITIVE
#15ARTIFICIAL OXYGEN CARRIER BLOOD PRODUCT
#16PIC1 INHIBITION OF MYELOPEROXIDASE OXIDATIVE ACTIVITY IN AN ANIMAL MODEL
#17METHODS RELATED TO ADMINISTERING IMMUNOSUPPRESSANTS AND THERAPEUTIC MACROMOLECULES AT A REDUCED PHARMACODYNAMICALLY EFFECTIVE DOSE
#18DEVICES AND METHODS FOR DELIVERING THERAPEUTICS
#19ENGINEERED MEGANUCLEASES SPECIFIC FOR RECOGNITION SEQUENCES IN THE HEPATITIS B VIRUS GENOME
#20THERAPEUTIC ACID CERAMIDASE COMPOSITIONS AND METHODS OF MAKING AND USING THEM
#21COMPANION METHODS AND KITS FOR IL-2-BASED THERAPIES AND MESENCHYMAL STEM CELL-BASED THERAPIES
#22METHODS AND COMPOSITIONS RELATED TO COMBINED TREATMENT WITH ANTI-INFLAMMATORIES AND SYNTHETIC NANOCARRIERS COMPRISING AN IMMUNOSUPPRESSANT
#23USE OF THERMOSTABLE EXOSHELLS FOR LYOPHILIZATION OF LABILE SUBSTRATES
#24EXPRESSION CASSETTE COMBINATIONS AND USES THEREOF
#25PHARMACEUTICAL COMPOSITION COMPRISING BIOPHARMACEUTICAL DRUG COMPOUNDS
#26METHODS OF ADMINISTERING IMMUNOSUPPRESSANTS HAVING A SPECIFIED PHARMACODYNAMIC EFFECTIVE LIFE AND THERAPEUTIC MACROMOLECULES FOR THE INDUCTION OF IMMUNE TOLERANCE
#27PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ALCOHOLIC AND NONALCOHOLIC FATTY LIVER DISEASE
#28USE OF HSP70 AS A REGULATOR OF ENZYMATIC ACTIVITY
#29NOVEL COMBINATIONS FOR ANTIGEN BASED THERAPY
#30ENGINEERED MEGANUCLEASES SPECIFIC FOR RECOGNITION SEQUENCES IN THE HEPATITIS B VIRUS GENOME
#31Targeted Therapeutic Lysosomal Enzyme Fusion Proteins, Associated Formulations and Uses Thereof
#32METHODS OF TREATING AN OCULAR DISEASE OR DISORDER
#33ENZYME AND PROBIOTICS TAKEN WITH PROTEIN, CREATE A WHOLISTIC SYSTEM THAT PREVENTS THE NEGATIVE EFFECTS OF PROTEIN INDIGESTION ON GUT MICROBIOTA, PROMOTE MICROFLORA BALANCE, AND INCREASE THE BIOAVAILABILITY OF POSTBIOTICS
#34DELIVERY, USE AND THERAPEUTIC APPLICATIONS OF CRISPR SYSTEMS AND COMPOSITIONS FOR GENOME EDITING AS TO HEMATOPOIETIC STEM CELLS (HSCs)
#35DNA REPAIR COMPOSITION
#36Treatment Method and Product for Uterine Fibroids using Purified Collagenase
#37PIC1 inhibition of myeloperoxidase oxidative activity in an animal model
#38METHODS OF TREATMENT OF CANCER BY CONTINUOUS INFUSION OF COENZYME Q10
#39Method for Prohibiting and/or Treating an Eye Condition
#40USE OF PEPTIDYLGLYCINE ALPHA-AMIDATING MONOOXYGENASE (PAM) FOR THERAPEUTIC PURPOSE
#41ANGIOSTATIN NEUTRALIZING PEPTIDES DERIVED FROM ATP SYNTHASE ALPHA SUBUNIT
#42Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
#43METHODS AND COMPOSITIONS RELATED TO COMBINED TREATMENT WITH ANTI-INFLAMMATORIES AND SYNTHETIC NANOCARRIERS COMPRISING AN IMMUNOSUPPRESSANT
#44LACTASE ENZYMES WITH IMPROVED PROPERTIES
#45METHODS PROVIDING A THERAPEUTIC MACROMOLECULE AND SYNTHETIC NANOCARRIERS COMPRISING IMMUNOSUPPRESSANT LOCALLY AND CONCOMITANTLY TO REDUCE BOTH TYPE 1 AND TYPE IV HYPERSENSITIVITY
#46PROCESSES FOR GENERATING SUPERIOR ANTI-TUMOR T-CELL EFFECTOR AND MEMORY CELLS
#47USE OF GLUTAMINE SYNTHETASE FOR TREATING HYPERAMMONEMIA
#48Use of glutamine synthetase for treating hyperammonemia
#49METHODS AND DEVICES FOR THE PRODUCTION AND DELIVERY OF BENEFICIAL FACTORS FROM STEM CELLS
#50Use of Hsp70 as a regulator of enzymatic activity
#51Devices and methods for delivering therapeutics
#52TARGETING OF THE CYTOSKELETON AS A THERAPEUTIC APPROACH FOR NEURODEGENERATIVE DISEASE
#53TARGETED THERAPEUTIC LYSOSOMAL ENZYME FUSION PROTEINS, ASSOCIATED FORMULATIONS AND USES THEREOF
#54ENGINEERED MEGANUCLEASES SPECIFIC FOR RECOGNITION SEQUENCES IN THE HEPATITIS B VIRUS GENOME
#55Direct-fed microbials
#56MRNA BASED ENZYME REPLACEMENT THERAPY COMBINED WITH A PHARMACOLOGICAL CHAPERONE FOR THE TREATMENT OF LYSOSOMAL STORAGE DISORDERS
#57Sol-Gel Vaults and Methods of Making and Using Thereof
#58METHODS OF ADMINISTERING IMMUNOSUPPRESSANTS HAVING A SPECIFIED PHARMACODYNAMIC EFFECTIVE LIFE AND THERAPEUTIC MACROMOLECULES FOR THE INDUCTION OF IMMUNE TOLERANCE
#59Pharmaceutical composition for preventing or treating obesity or sarcopenia, containing IF1 as active ingredient
#60NOVEL COMBINATIONS FOR ANTIGEN BASED THERAPY
#61ERYTHROPOIETIN AND FIBRONECTIN COMPOSITIONS FOR THERAPEUTIC AND COSMETIC APPLICATIONS
#62PIC1 inhibition of myeloperoxidase oxidative activity in an animal model
#63Protein-containing aqueous liquid formulation
#64FUNGAL SPECIES, COMPOSITIONS DERIVED THEREFROM, AND USES THEREOF
#65Treatment method and product for uterine fibroids using purified collagenase
#66Enzyme Granules
#67Engineered meganucleases specific for recognition sequences in the Hepatitis B virus genome
#68Therapeutic bacteriocins
#69USE OF GLUTAMINE SYNTHETASE FOR TREATING HYPERAMMONEMIA
#70GASTROINTESTINAL TRACT THERAPEUTIC AGENTS
#71Methods of treating an ocular disease or disorder
#72NEW USE OF CNF1
#73NUTRIENT COMPOSITIONS HAVING ENHANCED BIOAVAILABILITY
#74Treatment Method and Product for Uterine Fibroids using Purified Collagenase
#75MANNOSE-6-PHOSPHATE BEARING PEPTIDES FUSED TO LYSOSOMAL ENZYMES
#76Restoring function of tumour acidified T cells
#77TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE OR PREVENT ANAPHYLAXIS IN RESPONSE TO A NON-ALLERGENIC ANTIGEN
#78Oncolytic virotherapy with helper-dependent adenoviral-based vectors expressing immunomodulatory molecules
#79Composition To Support Healthy Brain Function
#80Stable probiotic composition for the management of lactose intolerance
#81Synthetic peptides, pharmaceutical compositions comprising the same, and uses thereof in treating thromboembolism-related diseases
#82Targeted therapeutic lysosomal enzyme fusion proteins, associated formulations and uses thereof
#83Engineered meganucleases specific for recognition sequences in the hepatitis B virus genome
#84PIC1 inhibition of myeloperoxidase oxidative activity in an animal model
#85THE TRANSDERMAL USE OF CYANOBACTERIAL ALGAE, AND/OR EXTRACTS THEREOF, VIA LOW OR HIGH INTENSITY TRANSPORATION DEVICES FOR BEAUTY AND HEALTH ENHANCING PURPOSES
#86Amphiphile-Polymer Particles
#87INHIBITION OF SGK1 IN THE TREATMENT OF HEART CONDITIONS
#88Compounds and methods for treatment and prevention of Flavivirus infection
#89Polypeptide set to be used in light dependent gene recombination
#90Use of Hsp70 as a regulator of enzymatic activity
#91Use of HSP70 as a regulator of enzymatic activity
#92METHODS RELATED TO ADMINISTERING IMMUNOSUPPRESSANTS AND THERAPEUTIC MACROMOLECULES AT A REDUCED PHARMACODYNAMICALLY EFFECTIVE DOSE
#93Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both type I and type IV hypersensitivity
#94Treatment Method and Product for Uterine Fibroids using Purified Collagenase
#95METHODS COMPRISING DOSING COMBINATIONS FOR REDUCING UNDESIRED HUMORAL IMMUNE RESPONSES
#96METHODS OF ADMINISTERING IMMUNOSUPPRESSANTS HAVING A SPECIFIED PHARMACODYNAMIC EFFECTIVE LIFE AND THERAPEUTIC MACROMOLECULES FOR THE INDUCTION OF IMMUNE TOLERANCE
#97COMPOSITIONS, METHODS AND KITS FOR CHARACTERIZING AND SCREENING FOR SMALL CELL OVARIAN CARCINOMA
#98Direct-fed microbials
#99Methods for treating nuclear factor kappa-light-chain-enhancer of activated B cell (NF-KB) dysregulation in a host in need thereof using eggshell membrane compositions
#100COMPLEX FOR DRUG DELIVERY AND STABILIZATION AND PREPARATION METHOD THEREOF
#101Fatty acid formulations and methods of use thereof
#102ONCOGENIC ALTERNATIVE SPLICING SWITCH OF PACE4 IN CANCER
#103Method for promoting insulin secretion
#104Method for making glucagon and insulin restore normal balance
#105Arginine and its use as a T cell modulator
#106Engineered meganucleases specific for recognition sequences in the hepatitis B virus genome
#107Identification of unique gene expression profiles in children with regressive autism spectrum disorder (ASD) and Ileocolitis
#108Pharmaceutical composition containing a mixture of proenzymes and enzymes
#109Therapeutic acid ceramidase compositions and methods of making and using them
#110METHODS TO TREAT HEART FAILURE
#111Enzyme Granules
#112PIC1 inhibition of myeloperoxidase oxidative activity in an animal model
#113Devices and methods for delivering therapeutics
#114COMPOSITION COMPRISING AT LEAST ONE ENZYME AND AT LEAST ONE MICROBICIDAL MOLECULE FOR THE PREVENTION OR TREATMENT OF POST-IMPLANT INFECTIONS
#115ERYTHROPOIETIN AND FIBRONECTIN COMPOSITIONS FOR THERAPEUTIC AND COSMETIC APPLICATIONS
#116Methods for treating heart failure using beta-ARKnt peptide
#117MESSENGER RNA BASED VIRAL PRODUCTION
#118PROCESSES FOR GENERATING SUPERIOR ANTI-TUMOR T-CELL EFFECTOR AND MEMORY CELLS
#119ERYTHROPOIETIN AND FIBRONECTIN COMPOSITIONS FOR THERAPEUTIC AND COSMETIC APPLICATIONS
#120Fungal species, compositions derived therefrom, and uses thereof
#121Lysosomal acid lipase and PPAR gamma ligands as immune therapies for cancer treatment
#122Artificial Red Blood Cell Having Ability to Inhibit Conversion of Hemoglobin into Methemoglobin
#123Proteinaceous compounds and uses therefor
#124Compounds and methods for stabilizing thrombin activity
#125Methods for inhibiting tumor growth
#126Composition For Enzymatic Debridement
#127Methods of sensitizing tumor cells to weak base chemotherapeutic drugs
#128Methods of treatment of cancer by continuous infusion of coenzyme Q10
#129Method for producing hyaluronidase conjugate with polyethylenepiperazine derivatives and the use of the conjugate produced
#130Collagenase-derived peptides promote tissue regeneration and wound healing
#131Methods for treating nuclear factor kappa-light-chain-enhancer of activated B cell (NF-κB) dysregulation in a host in need thereof using eggshell membrane compositions
#132Methods of treating an ocular disease or disorder
#133Dry pad
#134Methods and compositions related to combined treatment with antiinflammatories and synthetic nanocarriers comprising an immunosuppressant
#135Combination of bactericidal agent with a lysosomotropic alkalinising agent for the treatment of a bacterial infection
#136Peptide inhibitors of telomerase translocation and therapeutic uses thereof
#137Inhibition of SGK1 in the treatment of heart conditions
#138Methods and compositions for modulation of blood-neural barrier
#139WATER-SOLUBLE LIPOPHILIC NATURAL COMPOUND FORMULATIONS
#140INHIBITION OF CANCER GROWTH AND METASTASIS
#141COMPOSITIONS AND METHODS FOR IMPROVING ENZYME REPLACEMENT THERAPY FOR LYSOSOMAL STORAGE DISEASES
#142Therapeutic acid ceramidase compositions and methods of making and using them
#143Cancer specific-splicing ribozyme and use thereof
#144Use of Hsp70 as a regulator of enzymatic activity
#145Methods and devices for the production and delivery of beneficial factors from adipose-derived stem cells
#146Treatment with an IL-2 based therapy
#147Topical Compositions And Methods For Stimulating MIR-146A In Skin Cells
#148Necroptosis Signaling as a Therapeutic Target for Alzheimer's Disease
#149Hollow silica nanoparticles with encapsulated bioactive ingredients, preparation process and applications thereof
#150DNA repair skin care composition
#151Engineered exosomes for the delivery of bioactive cargo using transmembrane tetraspanins
#152COMPOUNDS AND METHODS FOR TREATMENT AND PREVENTION OF FLAVIVIRUS INFECTION
#153AMNIOTIC FLUID-DERIVED PREPARATIONS
#154Compositions and Methods for Treating Glaucoma
#155MUSCLE-SPECIFIC CRISPR/CAS9 EDITING OF GENES
#156Cardiovascular disease treatment and prevention
#157Method And Compositions For Treating Skin
#158DELIVERY, USE AND THERAPEUTIC APPLICATIONS OF CRISPR SYSTEMS AND COMPOSITIONS FOR GENOME EDITING AS TO HEMATOPOIETIC STEM CELLS (HSCs)
#159Escorted and functionalized guides for CRISPR-Cas systems
#160Treatment Method and Product for Uterine Fibroids using Purified Collagenase
#161Enzyme Granules
#162HOMOGENOUS COMPOSITION AND METHODS OF MAKING THE SAME
#163CAPSULE FOR THE ORAL ADMINISTRATION OF BIOPHARMACEUTICALS
#164Amphiphile-polymer particles
#165Acceleration of diabetic wound healing
#166Container and closure
#167Nano-scale delivery device and uses thereof
#168Direct-fed microbials
#169Mannose-6-phosphate bearing peptides fused to lysosomal enzymes
#170REGULATED GENETIC SUICIDE MECHANISM COMPOSITIONS AND METHODS
#171Sugar Derivatives Comprising Sulfur-Containing Moieties And Methods Of Making Same And Methods Of Using The Same For The Treatment Of MPS IIIC
#172ENZYME FORTIFIED FOODS; ADD-ONS, SUSPENDED AND COATED PROCESSES
#173Therapeutic conjugates with sulfated dendrimers for intracellular targeting
#174Targeting peptides for directing adeno-associated viruses (AAVs)
#175Methods and compositions for modulation of blood-neural barrier
#176Fatty acid formulations and methods of use thereof
#177Non-digestible sugar-coated products and process
#178Supplemented antacid formulation
#179Nanoparticles comprising aminoacyl tRNA synthetase and anticancer composition comprising same
#180Pdia4 protein as a target for diagnosis, monitoring and treatment of diabetes
#181WOUND HEALING COMPOSITION
#182Therapeutic hyperbranched polyglycerol encapsulated biomolecules
#183Toroidal mesoporous silica nanoparticles (TMSNPs) and related protocells
#184Therapeutic target for musculoskeletal inflammation
#185Methods and materials for treatment of Pompe's disease
#186COMPOSITION
#187Use of Hsp70 as a regulator of enzymatic activity
#188Methods and compositions for enhancing intranasal delivery of therapeutic agents
#189HYALURONIC ACID FORMULATION
#190Inhibition of SGK1 in the treatment of heart conditions
#191Methods for inhibiting tumor growth
#192Nanozymes, methods of making nanozymes, and methods of using nanozymes
#193Cardiovascular disease treatment and prevention
#194Cardiovascular disease treatment and prevention
#195Compositions, methods, and devices for dialysis
#196Method of suppressing gene transcription through histone lysine methylation
#197MESSENGER RNA BASED VIRAL PRODUCTION
#198Role of a cluster of long noncoding RNA transcripts in protecting the heart from pathological hypertrophy
#199METHOD AND PROCESS FOR THE PRODUCTION OF MULTI-COATED RECOGNITIVE AND RELEASING SYSTEMS
#200Wound healing compositions comprising biocompatible cellulose hydrogel membranes and methods of use thereof
#201Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
#202Therapeutic acid ceramidase compositions and methods of making and using them
#203Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications
#204Compositions and methods for preventing infection of a wound and for advancing the healing process
#205Protein Delivery System and Method of Making Same
#206Hard capsule formulation
#207Identification of unique gene expression profiles in children with regressive autism spectrum disorder (ASD) and ileocolitis
#208Osmotic drying of all-aqueous emulsions
#209Inhibition of cancer growth and metastasis
#210Combination treatment for amyotrophic lateral sclerosis (ALS)
#211PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES USING SYSTEMS AND METHODS FOR TRANSDERMAL NITRIC OXIDE DELIVERY
#212Compositions and Methods for Regulating Cytochrome c-Mediated Apoptosis by tRNA
#213Water-soluble lipophilic natural compound formulations
#214Use of proteases for gluten intolerance
#215Methods and compounds for increasing threonyl-tRNA synthetase activity
#216Exfoliative hair retention-promoting formulation
#217Methods of treatment of cancer by continuous infusion of coenzyme Q10
#218Modulation of TLR4-signaling pathway
#219Compounds and methods for stabilizing thrombin activity
#220Polypeptide mixes with antibacterial activity
#221Food-Induced Antisecretory Proteins
#222Diabetic nutritional composition
#223Nanocarriers with multi-photon response elements
#224Compositions and methods of use for (pro)renin receptor
#225Means and methods for treating or diagnosing IDH1 R132H mutant-positive cancers
#226PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES USING SYSTEMS AND METHODS FOR TRANSDERMAL NITRIC OXIDE DELIVERY
#227Methods of administering immunosuppressants having a specified pharmacodynamic effective life and therapeutic macromolecules for the induction of immune tolerance
#228Methods comprising dosing combinations for reducing undesired humoral immune responses
#229Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both type I and type IV hypersensitivity
#230Tolerogenic synthetic nanocarriers to reduce or prevent anaphylaxis in response to a non-allergenic antigen
#231Methods related to administering immunosuppressants and therapeutic macromolecules at a reduced pharmacodynamically effective dose
#232NEURODEGENERATIVE DISEASES AND METHODS OF MODELING
#233BIODEGRADABLE BONE FILLERS, MEMBRANES AND SCAFFOLDS CONTAINING COMPOSITE PARTICLES
#234Treatment method and product for uterine fibroids using purified collagenase
#235Cardiovascular disease treatment and prevention
#236CARDIOVASCULAR DISEASE TREATMENT AND PREVENTION
#237Surgical Compositions
#238Treatment method and product for uterine fibroids using purified collagenase
#239Prussian blue-inspired constructs for multimodal imaging and therapy
#240Fast-setting alkoxysilane spray foams
#241CRISPR-Cas systems and methods for altering expression of gene products
#242ERYTHROPOIETIN AND FIBRONECTIN COMPOSITIONS FOR THERAPEUTIC AND COSMETIC APPLICATIONS
#243Compositions and methods for treating cancer
#244Composition useful for the treatment of lipid metabolism disorders
#245Serum S100B And Uses Thereof
#246SIN3B COMPLEX INHIBITION FOR PREVENTING HEMATOLOGIC CHEMOTHERAPY- AND RADIOTHERAPY-INDUCED CYTOTOXICITY
#247Melatonin-based treatment and diagnosis of bile duct disease
#248Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
#249Methods and compositions for enhancing intranasal delivery of therapeutic agents
#250Use of HSP70 as a regulator of enzymatic activity
#251Cancer tumor encapsulation procedure
#252COMPOSITIONS FOR PREPARING A COFFEE BEVERAGE COMPRISING HYDROLYSED CHLOROGENIC ACID
#253RECOMBINANT HUMAN CLN2 PROTEIN AND METHODS OF ITS PRODUCTION AND USE
#254Methods and materials for treatment of pompe's disease
#255METHODS OF TREATING CANCER USING OPIOD RETARGETED ENDOPEPIDASES
#256Botulinum toxin for smoking cessation
#257DIETARY SUPPLEMENT FOR ENHANCING ANIMAL HEALTH
#258Treatment of Neurocutaneous Syndrome, Including Compositions, Methods and Uses Thereof
#259SYNTHETIC MATRIX VESICLES FOR BIOMIMETIC MINERALIZATION
#260Treatment of Neurocutaneous Syndrome, Including Compositions, Methods and Uses Thereof
#261METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY
#262Anticancer fusion protein comprising trail
#263Composition for enzymatic debridement
#264COMPOSITIONS AND METHODS FOR REMOVAL OR DESTRUCTION OF AMYLOID FIBRIL OR AMYLOID ADHESIN COMPRISING AGGREGATES
#265Use of proteases for gluten intolerance
#266Nanocarriers with multi-photon response elements
#267Compositions and Methods for Regulating Cytochrome c-Mediated Apoptosis by tRNA
#268Wound healing compositions comprising biocompatible cellulose hydrogel membranes and methods of use thereof
#269Method for cosmetically treating caspase-14 deficiency
#270Fatty acid formulations and methods of use thereof
#271Methods and compositions for modulation of blood-neural barrier
#272Dosage forms of plant-derived cathartics
#273Enzyme Granules
#274ENZYME GRANULES
#275ENZYME GRANULES
#276Methods of treating a deficiency of functional tripeptidyl peptidase I (CLN2) protein
#277METHODS FOR IDENTIFYING AND COMPOUNDS USEFUL FOR THE DIAGNOSIS AND TREATMENT OF DISEASES INVOLVING INFLAMMATION
#278Lecithin carrier vesicles and methods of making the same
#279Prenatal enzyme replacement therapy for hypophosphatasia
#280Use of Hsp70 as a regulator of enzymatic activity
#281TWO-STEP TARGETED TUMOR THERAPY WITH PRODRUG ENCAPSULATED IN NANOCARRIER
#282Non-digestible sugar-coated products and process
#283Compositions and methods for treating cancer
#284USE OF PROTEASES FOR GLUTEN INTOLERANCE
#285Method of suppressing gene transcription through histone lysine methylation
#286ERYTHROPOIETIN AND FIBRONECTIN COMPOSITIONS FOR THERAPEUTIC AND COSMETIC APPLICATIONS
#287Methods of Treating Cancer Using Opioid Retargeted Endopepidases
#288Compositions for preparing a coffee beverage comprising hydrolysed chlorogenic acid
#289Methods of treating a deficiency of functional tripeptidyl peptidase I (CLN2) protein
#290CHEWABLE DRUG
#291Procaspase 8-mediated disease targeting
#292REGULATED GENETIC SUICIDE MECHANISM COMPOSITIONS AND METHODS
#293Enzyme Granules
#294Method for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and a medicinal preparation for carrying out said method
#295Methods for identifying agents that affect the survival of motor neurons
#296Skin repair compositions comprising circadian gene activators and a synergistic combination of 1 gene activators
#297Method for Attachment of Biomolecules to Medical Device Surfaces
#298Methods for Identifying and Targeting Tumor Stem Cells Based on Nuclear Morphology
#299METHOD FOR TREATING HEART ATTACKS, STROKES AND DIABETIC CRISIS BY UTILIZING MODIFIED VIRUS VIRIONS TO INSERT NECESSARY PROTEIN MOLECULES AND VITAL NUTRIENTS INTO TARGETED CELLS
#300MEDICAL DEVICE FOR TREATING DIABETES MELLITUS, OBESITY, CHRONIC FATIGUE, AGING, AND OTHER MEDICAL CONDITIONS BY UTILIZING MODIFIED VIRUS VIRIONS TO INSERT MESSENGER RIBONUCLEIC ACID MOLECULES INTO CELLS